Modest rise in UK cancer cases but substantial decline in deaths over last 25 years

Results are, overall, positive and reassuring, but further work is needed to address rise in some less common types of cancer, say experts

2024-03-14

(Press-News.org) Cases of cancer among UK men and women aged 35-69 years have seen a modest rise over the last quarter of a century, but there has also been a substantial decline in death rates, finds a study published by The BMJ today.

The results show a fall in death rates for all cancers combined and for 17 out of 22 cancer types examined, which the researchers say is likely due to fewer people smoking, screening programmes, and improved treatment, while a rise in some less common cancers may be due to higher levels of overweight and obesity, among other risk factors.

The availability of comprehensive UK cancer registration data since 1993 makes comparison of cancer cases (incidence) and mortality trends over 25 years possible, but no recent studies have investigated these trends over such a long time frame.

To fill this knowledge gap, researchers used UK-wide cancer registration and population data to examine trends in cancer cases and deaths for all cancers combined and 22 common cancers in men and women aged 35-69 years who were newly diagnosed with or died from cancer between 1993 to 2018.

Results show the number of cancer cases rose by 57% for men (from 55,014 cases registered in 1993 to 86,297 in 2018) and by 48% for women (60,187 to 88,970).

When analysed by age, the average annual increase in cases was a modest 0.8% in both sexes, predominantly driven by increases in prostate (male) and breast (female) cancers.

However, four less common cancers showed concerning increases in cases (more than 2% per year) in both sexes: liver, melanoma skin, oral, and kidney.

Overall, the number of cancer deaths fell over the 25 year period, by 20% in men (from 32,878 to 26,322) and 17% in women (28,516 to 23,719), with death rates falling even higher by 37% in men and 33% in women when accounting for the growing and ageing population over the 25 year period.

After accounting for differences in age, deaths for all cancers combined fell by 2% per year in men and by 1.6% per year in women across nearly all the cancers examined.

The largest declines were noted for stomach (5.1%), mesothelioma (4.2% from 2001), and bladder cancers (3.2%) in men and stomach (4.2%), cervical cancers (3.6%) and non-Hodgkin’s lymphoma (3.2%) in women.

Only liver, oral, and uterine cancers showed an annual increase in deaths of 1% or more.

The authors note that this decline in deaths across the most common cancers in both sexes is likely a reflection of the successes in cancer prevention, earlier detection and improved diagnostic tests and treatment. In contrast, increased levels of alcohol intake and excess body weight are likely factors in the rise in rates of some less common cancers.

This is an observational study so can’t establish cause, and the authors acknowledge that cancers not included in the study could well be showing different trends. Excluding older people, where rates of cancer are higher, and being unable to take account of ethnic group and deprivation may have also had an effect.

Nevertheless, by using high quality cancer registry data and focusing only on the 35-69 age range, they present a clear and reliable comparative picture of UK cancer incidence across 25 years.

The conclusions that can be drawn from this analysis are, overall, positive and reassuring, they say. “This analysis also provides a benchmark for the following decade, which will include the impact of covid-19 on cancer incidence and outcomes.”

These findings are grounds for optimism, agrees Dr Freddie Bray at the International Agency for Research on Cancer (IARC) in a linked editorial.

However, some early warning signs should raise alarm bells, including the possibility of excess cancer deaths in future years resulting from delays in diagnosis and treatment during the covid-19 pandemic. The rising death rates from common cancers, including among younger (unscreened) age groups, are also of immediate concern, he adds.

“Effective interventions that increase awareness of modifiable risk factors for cancer—including, but not limited to excess body weight and harmful alcohol consumption—must be urgently prioritised,” he concludes.

[Ends]

END

ELSE PRESS RELEASES FROM THIS DATE:

Cancer deaths plummet in middle-aged people

2024-03-14

A first of its kind study by Cancer Research UK reveals premature cancer death rates in 35–69-year-olds fell by more than a third over 25 years Improvements in the UK are a result of smokefree policies, prevention measures, early detection programmes like cancer screening, and more effective treatment options But the study paints a mixed picture with cancer cases on the rise and cancer mortality rates still too high The charity’s manifesto, ‘Longer, ...

How to upcycle low-energy light

2024-03-14

To combine two low-energy photons into one high-energy photon efficiently, the energy must be able to hop freely, but not too quickly, between randomly oriented molecules of a solid. This Kobe University discovery provides a much-needed design guideline for developing materials for more efficient PV cells, displays, or even anti-cancer therapies. Light of different colors has different energies and is therefore useful for very different things. For the development of more efficient PV cells, OLED displays, or anti-cancer therapies it is desirable to be able to upcycle two low-energy photons into a high-energy photon, ...

Lives could be saved from tropical disease with new rapid test

2024-03-14

Globally, more than half of patients die after infection with the neglected tropical disease, melioidosis, often before they are diagnosed1. A new rapid test could save lives by diagnosing patients in hours, rather than several days taken by current bacterial culture methods, meaning they receive the correct antibiotics faster. The test uses CRISPR to detect a genetic target that is specific to Burkholderia pseudomallei, the bacterium that causes melioidosis, with 93 per cent sensitivity. It was ...

Revolutionary chronic wound treatment could help millions

2024-03-14

Revolutionary chronic wound treatment could help millions A team of international scientists has developed an effective treatment for preventing infection in chronic wounds that does not involve antibiotics The treatment involves the plasma (electrical gas) activation of hydrogel dressings to produce a unique mix of different chemical oxidants that applied to the wound are effective in decontaminating and aiding healing in chronic wounds The new method is a significant advance that could revolutionise the treatment of diabetic foot ulcers and internal wounds More than 540 million people ...

First-of-its-kind super minigene to boost spinal muscular atrophy research

2024-03-13

AMES, Iowa – Ravindra Singh has spent years studying a gene that when missing or mutated causes spinal muscular atrophy (SMA), a deadly disease that’s among the most common genetic disorders in children. His team’s latest work will make the search for treatments even more effective in the years to come. Singh, a professor of biomedical science at Iowa State University, led an eight-year project to create a truncated version of the Survival Motor Neuron 2 (SMN2) gene to facilitate quicker, cheaper and less fragmented research. Nucleic Acids Research, a peer-reviewed ...

NYU Tandon study exposes failings of measures to prevent illegal content generation by text-to-image AI models

2024-03-13

Researchers at NYU Tandon School of Engineering have revealed critical shortcomings in recently proposed methods aimed at making powerful text-to-image generative AI systems safer for public use. In a paper that will be presented at the Twelfth International Conference on Learning Representations (ICLR), taking place in Vienna on May 7 - 11, 2024, the research team demonstrates how techniques that claim to "erase" the ability of models like Stable Diffusion to generate explicit, copyrighted, or otherwise unsafe ...

New analysis shows tirzepatide consistently reduces bodyweight regardless of body mass index (BMI) before treatment

2024-03-13

*Note – this is an early press release from the European Congress on Obesity in Venice, Italy 12-15 May. Please credit the congress when using this research* Tirzepatide, a medication authorised to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardless of the patient’s body mass index (BMI before treatment), from the range of overweight to class III obesity. The study, to be presented at this year’s European Congress on Obesity (Venice, Italy, 12-15 May) is by Prof Carel Le Roux, University ...

Tirzepatide reduces body weight and waist circumference in people living with overweight or obesity regardless of duration of their condition

2024-03-13

*Note – this is an early press release from the European Congress on Obesity in Venice, Italy 12-15 May. Please credit the congress when using this research* New research to be presented at this year’s European Congress on Obesity (Venice, Italy, May 12-15) shows that the obesity medication tirzepatide consistently reduces bodyweight and waist circumference regardless of the length of time the person has been living with overweight or obesity. The study is by Dr Giovanna Muscogiuri, University of Naples Federico II, Naples, Italy, and colleagues. Tirzepatide (Mounjaro®) was approved by the US Food and ...

Scientists use novel technique to create new energy-efficient microelectronic device

2024-03-13

Breakthrough could help lead to the development of new low-power semiconductors or quantum devices. As the integrated circuits that power our electronic devices get more powerful, they are also getting smaller. This trend of microelectronics has only accelerated in recent years as scientists try to fit increasingly more semiconducting components on a chip. Microelectronics face a key challenge because of their small size. To avoid overheating, microelectronics need to consume only a fraction of the electricity of conventional electronics while still operating at peak performance. Researchers at the U.S. Department of Energy’s (DOE) Argonne National Laboratory ...

Jay Sexton receives 2024 SEC Faculty Achievement Award

2024-03-13

COLUMBIA, Mo. — In fourth grade, Jay Sexton first encountered one of James McPherson’s most influential works, “Battle Cry of Freedom: The Civil War Era.” That experience would ignite a lifelong passion for studying history and establish an ongoing legacy as a preeminent scholar in the study of the American story. As director of the Kinder Institute on Constitutional Democracy at the University of Missouri — a world-renowned academic center devoted to the study of the American founding, including constitutional ...